Association between estrogen receptor α polymorphisms and equol production, and its relation to bone mass

International Journal of Molecular Medicine

Volumn 23, Issue 6, 2009, Pages 793-798

  Katsuyama, Hironobu ^a   Arii, Masayuki ^b   Tomita, Masafumi ^a   Hidaka, Kazuo ^a   Watanabe, Yoko ^a   Tamechika, Yoshie ^a   Okuyama, Toshiko ^a   Fushimi, Shigeko ^a   Maeda, Noriko ^c   Higashimura, Tsutomu ^c   Fukunaga, Masao ^a   Saijoh, Kiyofumi ^d  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b KIKKOMAN CORPORATION   (Japan)

^c Kosei Hospital   (Japan)

^d KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone turnover markers; Equol producer; Estrogen receptor polymorphism; Logistic regression analysis; osteosono assessment index

Indexed keywords

DNA; EQUOL; ESTROGEN RECEPTOR ALPHA;

ADULT; ALLELE; ARTICLE; BLOOD LEVEL; BODY MASS; BONE DENSITY; BONE MASS; BONE TURNOVER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FOOD INTAKE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOSONO ASSESSMENT INDEX; PRIORITY JOURNAL; RISK REDUCTION; SOYBEAN;

ADULT; ANALYSIS OF VARIANCE; BONE DENSITY; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; ISOFLAVONES; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 67649537439     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000194     Document Type: Article

References (31)

1. Eisman JA: Genetics of osteoporosis. Endocr Rev 20: 788-804, 1999.
2. Yamazaki K, Kushida K, Ohkuma A, Sano M and Inoue T: Ultrasound bone densitometry of the os calcis in Japanese women. Osteoporos Int 4: 220-225, 1994.
3. Turner RT, Riggs BL and Spelsberg TC: Skeletal effects of estrogen. Endocr Rev 15: 275-300, 1994.
4. Kobayashi S, Inoue S, Hosoi T, Ouchi Y, Shiraki M and Orimo H: Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res 11: 306-311, 1996.
5. Valimaki VV, Piippo K, Valimaki S, Loyttyniemi E, Kontula K and Valimaki MJ: The relation of the XbaI and PvuII polymorphisms of the estrogen receptor gene and the CAG repeat polymorphism of the androgen receptor gene to peak bone mass and bone turnover rate among young healthy men. Osteoporos Int 16: 1633-1640, 2005.
6. Ioannidis JP, Stavrou I, Trikalinos TA, et al: Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis. J Bone Miner Res 17: 2048-2060, 2002.
7. Ioannidis JP, Ralston SH, Bennett ST, et al: Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA 292: 2105-2114, 2004.
8. Herrington DM, Howard TD, Brosnihan KB, et al: Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 105: 1879-1882, 2002.
9. Salmen T, Heikkinen AM, Mahonen A, et al: The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal women. J Bone Miner Res 15: 2479-2486, 2000.
10. Chen YM, Ho SC, Lam SSH, Ho SSS and Woo JLF: Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: A double-blind, randomized, controlled trial. J Clin Endocrinol Metab 88: 4740-4747, 2003.
11. McCarty MF: Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits. Med Hypotheses 66: 1093-1114, 2006.
12. Rachon D, Seidlova-Wuttke D, Vortherms T and Wuttke W: Effects of dietary equol administration on ovariectomy induced bone loss in Sprague-Dawley rats. Maturitas 58: 308-315, 2007.
13. Takahashi K, Yoshimura Y and Katashima R: Development of food frequency and intake survey by questionnaire method. Bull Shikoku Univ 5: 23-35, 1996. (In Japanese)
14. Garnero P, Grimaux M, Seguin P and Delmas PD: Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro. J Bone Miner Res 9: 255-264, 1994.
15. Seibel MJ and Woitge HW: Basic principle and clinical applications of biochemical markers of bone metabolism. J Clin Densitom 2: 299-321, 1999.
16. Benton ME, Price PA and Suttie JW: Multi-site-specificity of the vitamin K-dependent carboxylase: In vitro carboxylation of des-γ-carboxylated bone Gla protein and des-γ-carboxylated pro bone Gla protein. Biochemistry 34: 9541-9551, 1995.
17. Nakao M, Nishiuchi Y, Nakata M, Kimura T and Sakakibara S: Synthesis of human osteocalcins: γ-carboxyglutamic acid at position 17 is essential for a calcium-dependent conformational transition. Pept Res 7: 171-174, 1994.
18. Hannon R and Eastell R: Preanalytical variability of biochemical markers of bone turnover. Osteoporos Int 6: s30-s44, 2000.
19. Hidaka K, Higashi M, Watanabe Y, Tomita M, Katsuyama H and Tamechika Y: An improved analytical method for detection of isoflavones in plasma by high performance liquid chromatography. Kawasaki Ikaishi Arts Sci 33: 9-15, 2007.
20. Tsangalis D, Wilcox G, Shah NP and Stojanovska L: Bioavailability of isflavone phytoestrogens in postmenopausal women consuming soya milk fermented with probiotic bifidobacteria. Br J Nutr 93: 867-877, 2005.
21. Hur HG, Lay JO Jr, Beger RD, Freeman JP and Rafii F: Isolation of human intestinal bacteria metabolizing the natural isoflavone glycosides daidzin and genistin. Arch Microbiol 174: 422-428, 2000.
22. Atkinson C, Frankenfeld CL and Lampe JW: Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med 230: 155-170, 2005.
23. Setchell KD: Absorption and metabolism of soy isoflavones - from food to dietary supplements and adults to infants. J Nutr 130: 654s-655s, 2000.
24. Strand M, Soderstrom I, Wiklund PG, Hallmans G, Weinehall L, Soderberg S and Olsson T: Estrogen receptor alpha gene polymorphisms and first-ever intracerebral hemorrhage. Cerebrovasc Dis 24: 500-508, 2007.
25. Health and Welfare Statistics Association: J Health Welfare Stat. 55: 459, 2008. (In Japanese)
26. Mitra S, Desai M and Khatkhatay MI: Association of estrogen receptor α gene polymorphisms with bone mineral density in postmenopausal Indian women. Mol Genet Metab 87: 80-87, 2006.
27. Luukinen H, Kakonen SM, Petterson K, et al: Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. J Bone Miner Res 15: 2473-2478, 2000.
28. Brink E, Coxam V, Robins S, Wahala K, Cassidy A and Branca F: Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study. Am J Clin Nutr 87: 761-770, 2008.
29. Harkness LS, Fiedler K, Sehgal AR, Oravec D and Lerner E: Decreased bone resorption with soy isoflavone supplementation in postmenopausal women. J Womens Health 13: 1000-1007, 2004.
30. Branca F and Lorenzetti S: Health effects of phytoestrogens. In: Diet Diversification and Heath Promotion. Elmadfa I (ed). Vol. 57. Forum Nutr., Karger, Basel pp100-111, 2005.
31. Anderson JJB and Garner SC: The effect of phytoestrogens on bone. Nutr Res 17: 1617-1632, 1997.